...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Ovarian Cancer?

 

Thanks Golf & too those that reached out via pm​ etc​.

So much gratitude for having folks reach out regardless of our past or present posting history/battles etc, nothing else seems to matter​ much​ in times like this.

​Much appreciated & truly grateful​​ to all

 

Share
New Message
Please login to post a reply